Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Litzow

Showing results (151-160 of 457) with videos related to

Pageof 46
Sort By:
Blood Cancer Journal|March 9, 2018
Momelotinib therapy for myelofibrosis: a 7-year follow-upAyalew Tefferi, Daniela Barraco, Terra L Lasho, et al.
Science Advances|December 14, 2022
PAX5 epigenetically orchestrates CD58 transcription and modulates blinatumomab response in acute lymphoblastic leukemiaYizhen Li, Takaya Moriyama, Satoshi Yoshimura, et al.
Leukemia & Lymphoma|October 1, 2016
Allogeneic hematopoietic stem cell transplant in adult patients with myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN) overlap syndromesPrashant Sharma, Shivani S Shinde, Moussab Damlaj, et al.
American Journal of Hematology|September 16, 2018
Impact of clone size with a single cytogenetic abnormality on the revised International Prognostic Scoring System in myelodysplastic syndromesOmar Alkharabsheh, Salwa S Saadeh, Mrinal S Patnaik, et al.
Annals of Hematology|October 19, 2018
Frequency of venous thrombotic events in patients with myelodysplastic syndrome and 5q deletion syndrome during lenalidomide therapyOmar A Alkharabsheh, Salwa S Saadeh, Darci L Zblewski, et al.
British Journal of Haematology|October 7, 2009
Failure of three novel regimens to improve outcome for patients with relapsed or refractory acute myeloid leukaemia: a report from the Eastern Cooperative Oncology GroupMark R Litzow, Megan Othus, Larry D Cripe, et al.
Echocardiography (Mount Kisco, N.Y.)|November 10, 2019
Two-dimensional speckle-tracking strain detects subclinical cardiotoxicity in older patients treated for acute myeloid leukemiaGregory J Cascino, Woo Bin Voss, Jonathan Canaani, et al.
Annals of Hematology|January 25, 2020
Impact of marrow blasts percentage on high-grade myelodysplastic syndrome assessed using revised international prognostic scoring systemOmar Alkharabsheh, Mrinal M Patnaik, Naseema Gangat, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 11, 2016
Fludarabine-Busulfan Reduced-Intensity Conditioning in Comparison with Fludarabine-Melphalan Is Associated with Increased Relapse Risk In Spite of Pharmacokinetic DosingMoussab Damlaj, Hassan B Alkhateeb, Mehrdad Hefazi, et al.
Leukemia & Lymphoma|December 29, 2004
Intensified induction chemotherapy in adult acute myeloid leukemia followed by high-dose chemotherapy and autologous peripheral blood stem cell transplantation: an Eastern Cooperative Oncology Group trial (E4995)Peter A Cassileth, Sandra J Lee, Mark R Litzow, et al.
Pageof 46

Showing results (151-160 of 457) with videos related to

Sort By:
Pageof 46
Blood Cancer Journal|March 9, 2018
Momelotinib therapy for myelofibrosis: a 7-year follow-upAyalew Tefferi, Daniela Barraco, Terra L Lasho, et al.
Science Advances|December 14, 2022
PAX5 epigenetically orchestrates CD58 transcription and modulates blinatumomab response in acute lymphoblastic leukemiaYizhen Li, Takaya Moriyama, Satoshi Yoshimura, et al.
Leukemia & Lymphoma|October 1, 2016
Allogeneic hematopoietic stem cell transplant in adult patients with myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN) overlap syndromesPrashant Sharma, Shivani S Shinde, Moussab Damlaj, et al.
American Journal of Hematology|September 16, 2018
Impact of clone size with a single cytogenetic abnormality on the revised International Prognostic Scoring System in myelodysplastic syndromesOmar Alkharabsheh, Salwa S Saadeh, Mrinal S Patnaik, et al.
Annals of Hematology|October 19, 2018
Frequency of venous thrombotic events in patients with myelodysplastic syndrome and 5q deletion syndrome during lenalidomide therapyOmar A Alkharabsheh, Salwa S Saadeh, Darci L Zblewski, et al.
British Journal of Haematology|October 7, 2009
Failure of three novel regimens to improve outcome for patients with relapsed or refractory acute myeloid leukaemia: a report from the Eastern Cooperative Oncology GroupMark R Litzow, Megan Othus, Larry D Cripe, et al.
Echocardiography (Mount Kisco, N.Y.)|November 10, 2019
Two-dimensional speckle-tracking strain detects subclinical cardiotoxicity in older patients treated for acute myeloid leukemiaGregory J Cascino, Woo Bin Voss, Jonathan Canaani, et al.
Annals of Hematology|January 25, 2020
Impact of marrow blasts percentage on high-grade myelodysplastic syndrome assessed using revised international prognostic scoring systemOmar Alkharabsheh, Mrinal M Patnaik, Naseema Gangat, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 11, 2016
Fludarabine-Busulfan Reduced-Intensity Conditioning in Comparison with Fludarabine-Melphalan Is Associated with Increased Relapse Risk In Spite of Pharmacokinetic DosingMoussab Damlaj, Hassan B Alkhateeb, Mehrdad Hefazi, et al.
Leukemia & Lymphoma|December 29, 2004
Intensified induction chemotherapy in adult acute myeloid leukemia followed by high-dose chemotherapy and autologous peripheral blood stem cell transplantation: an Eastern Cooperative Oncology Group trial (E4995)Peter A Cassileth, Sandra J Lee, Mark R Litzow, et al.
Pageof 46